TITLE: Oral Oncolytics
CME credit awarded: 1.0
CE# (if applicable): 00192-EDII-787
CE credit issued: 1.25
Expiration Date: May 1, 2020 Reviewed / Reapproved: December 11, 2020
New Expiration Date: December 1, 2021
Patti Hawkins, PharmD, Director, NMMC Outpatient Infusion Services
Amanda Summers, PharmD, Pharmacist, NMMC Cancer Care
Disclosure: Patti Hawkins and Amanda Summers both have indicated that there are no disclosures to be made regarding this presentation.
The planning committee has also indicated that they have no disclosures.
Discuss the use of oral oncolytics with existing standards of care for cancer patients.